Expert perspectives on potential environmental risks from nanomedicines and adequacy of the current guideline on environmental risk assessment-Reference-Cited by-同舟云学术

Expert perspectives on potential environmental risks from nanomedicines and adequacy of the current guideline on environmental risk assessment

Published:2018 Issue:8 Volume:5 Page:1873-1889
ISSN:2051-8153
Container-title:Environmental Science: Nano
language:en
Short-container-title:Environ. Sci.: Nano

Author:

Mahapatra Indrani¹²³⁴^ORCID,Clark Julian R. A.¹²³⁴,Dobson Peter J.⁵⁶⁴⁷⁸,Owen Richard⁹¹⁰¹¹⁴,Lynch Iseult¹²³⁴^ORCID,Lead Jamie R.¹²¹³¹⁴¹⁵¹⁶

Affiliation:

1. School of Geography, Earth and Environmental Sciences

2. University of Birmingham

3. Birmingham

4. UK

5. The Queen's College

6. Oxford OX1 4AW

7. Warwick Manufacturing Group

8. University of Warwick

9. Department of Management

10. University of Bristol

11. Bristol

12. Center for Environmental Nanoscience and Risk

13. Department of Environmental Health Sciences

14. Arnold School of Public Health

15. University of South Carolina

16. Columbia

Abstract

Interviews conducted with 66 experts to gather their perspectives on environmental risks from nanomedicines and their responses analysed using qualitative content analysis.

Funder

University of Birmingham

Publisher

Royal Society of Chemistry (RSC)

Subject

General Environmental Science,Materials Science (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2018/EN/C8EN00053K

Reference121 articles.

1. Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review)

2. Stimuli-sensitive nanopreparations for combination cancer therapy

3. Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy

4. Hybrid PET-optical imaging using targeted probes

5. Nanomedicines in the EU—Regulatory Overview

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation of nanostructured carbon particles from sugarcane jaggery: Evaluation of their antioxidant and cytotoxic features;Diamond and Related Materials;2024-11

2. Regulation, Development, and Commercialization of Nano-Based Drugs;Nanotechnology in Drug Discovery;2024-07-04

3. Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials;Nano Today;2024-06

4. Insights in Pharmaceutical Pollution: The Prospective Role of eDNA Metabarcoding;Toxics;2023-11-05

5. Occurrence, fate, and potential risk of pharmaceutical pollutants in agriculture: Challenges and environmentally friendly solutions;Science of The Total Environment;2023-11